Neuroblastoma (NB) is a type of cancer that forms in certain types of nerve tissue. It most frequently starts from one of the adrenal glands, but can also develop in the neck, chest, abdomen, or spine. Symptoms may include bone pain, a lump in the abdomen, neck, or chest, or a painless bluish lump under the skin.
This report contains market size and forecasts of Neuroblastoma Drugs in Global, including the following market information:
Global Neuroblastoma Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Neuroblastoma Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Chemotherapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Neuroblastoma Drugs include Pfizer, Teva Pharmaceutical, Johnson & Johnson, Bristol-Myers Squibb and United Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Neuroblastoma Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neuroblastoma Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Neuroblastoma Drugs Market Segment Percentages, by Type, 2021 (%)
Chemotherapy
Immunotherapy
Others
Global Neuroblastoma Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Neuroblastoma Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Neuroblastoma Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Neuroblastoma Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neuroblastoma Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Neuroblastoma Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Teva Pharmaceutical
Johnson & Johnson
Bristol-Myers Squibb
United Therapeutics